ARCHIVES

Rituximab Prolonged Survival Of CLL In Phase III Study

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

Clinical Study Section’s Workload Up 50 Percent, Evidence That More Investigators Submitting R01s

January 17, 1992

In Brief: Surgical Oncology Program Announcements Due For Publication By June; AACR/ASCO Program

April 17, 1981

DCBD Board Approves Concept for Astrocytoma Molecular Probes

July 22, 1988

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

April 4, 1996

Key Cancer Legislation Remains Unfinished as Congress Departs for Election.

October 6, 2006